SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-08-004922
Filing Date
2008-03-17
Accepted
2008-03-17 16:44:29
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f38512e10vk.htm 10-K 1049234
2 EXHIBIT 10.34 f38512exv10w34.htm EX-10.34 295512
3 EXHIBIT 10.35 f38512exv10w35.htm EX-10.35 98979
4 EXHIBIT 21.1 f38512exv21w1.htm EX-21.1 2306
5 EXHIBIT 23.1 f38512exv23w1.htm EX-23.1 3663
6 EXHIBIT 31.1 f38512exv31w1.htm EX-31.1 10596
7 EXHIBIT 31.2 f38512exv31w2.htm EX-31.2 10784
8 EXHIBIT 32.1 f38512exv32w1.htm EX-32.1 4537
9 EXHIBIT 32.2 f38512exv32w2.htm EX-32.2 4727
10 GRAPHIC f38512f3851201.gif GRAPHIC 8428
  Complete submission text file 0000950134-08-004922.txt   1493537
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50577 | Film No.: 08693443
SIC: 2834 Pharmaceutical Preparations